Skip to Content

Sponsors

No results

Keywords

No results

Types

No results

Search Results

Events

No results
Search events using: keywords, sponsors, locations or event type
When / Where
All occurrences of this event have passed.
This listing is displayed for historical purposes.

Presented By: Regenerative Medicine Biosciences Initiative

Programmable Biomaterials/Regenerative Medicine Grand Challenge

Keynote Speaker: Richard McFarland, PhD, MD, Chief Regulatory Officer ARMI

Purple Pipette Purple Pipette
Purple Pipette
 Louis Reed on Unsplash
Programmable Biomaterials/Regenerative Medicine Grand Challenge #1

Theme: How to regenerate tissues/organs to optimally integrate with the host

Goal: Bring together clinicians, scientists, and engineers to explore new ideas and catalyze new collaborations to address key barriers to the translation of regenerative medicine technologies

Format: Short talks identifying clinical problems and emerging technologies, followed by breakout sessions to identify opportunities

Breakouts: Based on problems identified, what are transformative things UM can do to solve? We’re looking for big ideas that involve new, heterogeneous groups. Themes/challenges that emerge from breakouts will define an RFA

Outcome: Funding for collaborative proposals that emerge from the grand challenge session w/ criteria that proposals are novel and integrative, satisfying one or more of the following elements:
•High risk, cross-cutting, transformative
•Leverage strengths at UM in new ways
•Pull together new combinations of people
•Tackle new problems or existing problems in new ways
•Topics that will have greatest impact and potential for extramural funding
•We anticipate awarding 3 grants at ~100K each
Please join us for our 2-day VIRTUAL event January 24 and January 25.
Purple Pipette Purple Pipette
Purple Pipette
 Louis Reed on Unsplash

Co-Sponsored By

Livestream Information

 Zoom
January 24, 2022 (Monday) 1:00pm
Meeting ID: 97438202990

Explore Similar Events

  •  Loading Similar Events...

Back to Main Content